Wealth Enhancement Advisory Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.48M | Sell |
169,669
-8,841
| -5% | -$338K | 0.01% | 792 |
|
2025
Q1 | $6.92M | Buy |
178,510
+3,822
| +2% | +$148K | 0.01% | 716 |
|
2024
Q4 | $5.91M | Buy |
174,688
+13,039
| +8% | +$441K | 0.01% | 740 |
|
2024
Q3 | $6.61M | Sell |
161,649
-4,606
| -3% | -$188K | 0.01% | 641 |
|
2024
Q2 | $6.4M | Buy |
166,255
+8,989
| +6% | +$346K | 0.02% | 621 |
|
2024
Q1 | $6.74M | Buy |
157,266
+4,082
| +3% | +$175K | 0.02% | 592 |
|
2023
Q4 | $5.68M | Buy |
153,184
+78,527
| +105% | +$2.91M | 0.02% | 577 |
|
2023
Q3 | $2.71M | Buy |
+74,657
| New | +$2.71M | 0.01% | 757 |
|